Chronic Myeloproliferative Disorders Completed Phase 3 Trials for Panax quinquefolius whole (DB14296)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00719563American Ginseng in Treating Patients With Fatigue Caused by CancerSupportive Care